Details for New Drug Application (NDA): 208354
✉ Email this page to a colleague
The generic ingredient in AMBRISENTAN is ambrisentan. There are nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the ambrisentan profile page.
Summary for 208354
Tradename: | AMBRISENTAN |
Applicant: | Sigmapharm Labs Llc |
Ingredient: | ambrisentan |
Patents: | 0 |
Pharmacology for NDA: 208354
Mechanism of Action | Endothelin Receptor Antagonists |
Suppliers and Packaging for NDA: 208354
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
AMBRISENTAN | ambrisentan | TABLET;ORAL | 208354 | ANDA | Sigmapharm Laboratories, LLC | 42794-051 | 42794-051-08 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (42794-051-08) |
AMBRISENTAN | ambrisentan | TABLET;ORAL | 208354 | ANDA | Sigmapharm Laboratories, LLC | 42794-051 | 42794-051-22 | 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (42794-051-22) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Apr 10, 2019 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Apr 10, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription